Talphera (TLPH) Asset Writedowns and Impairment (2015 - 2023)
Talphera (TLPH) posted Asset Writedowns and Impairment of $7.0 million for Q1 2023, up 14808.51% on a QoQ basis from $47000.0 in Q4 2022.
Analysis
Talphera (TLPH) Asset Writedowns and Impairment (2015 - 2023) Analysis & Trends
Talphera has reported Asset Writedowns and Impairment for 5 years, with the latest figure at $7.0 million in Q1 2023.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $7.0 million in Q1 2023; TTM through Dec 2023 was $7.0 million, a 41.61% increase from a year earlier, with the FY2023 full-year figure at $6.9 million, up 38.5% from the prior year.
- Asset Writedowns and Impairment was $7.0 million for Q1 2023 at Talphera, up from $47000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $7.0 million in Q1 2023, with the low at $47000.0 in Q4 2022.
- Average Asset Writedowns and Impairment over 4 years is $2.3 million, with a median of $855000.0 recorded in 2019.
- The largest YoY upside for Asset Writedowns and Impairment was 94.2% in 2022 against a maximum downside of 94.2% in 2022.
- Over 4 years, Asset Writedowns and Impairment stood at $96000.0 in 2019, then soared by 743.75% to $810000.0 in 2021, then sank by 94.2% to $47000.0 in 2022, then surged by 14808.51% to $7.0 million in 2023.
- The last three Asset Writedowns and Impairment figures came in at $7.0 million (Q1 2023), $47000.0 (Q4 2022), and $4.9 million (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 7.01 Mn |
| Dec 31, 2022 | 47,000.00 |
| Jun 30, 2022 | 4.90 Mn |
| Dec 31, 2021 | 810,000.00 |
| Dec 31, 2019 | 96,000.00 |
| Sep 30, 2019 | 900,000.00 |
| Sep 30, 2015 | 500,000.00 |